Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Assets Average (2016 - 2025)

Historic Assets Average for Macrogenics (MGNX) over the last 13 years, with Q3 2025 value amounting to $258.1 million.

  • Macrogenics' Assets Average rose 1085.63% to $258.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.1 million, marking a year-over-year increase of 1085.63%. This contributed to the annual value of $280.0 million for FY2024, which is 324.99% down from last year.
  • Per Macrogenics' latest filing, its Assets Average stood at $258.1 million for Q3 2025, which was up 1085.63% from $235.0 million recorded in Q2 2025.
  • Macrogenics' Assets Average's 5-year high stood at $430.7 million during Q2 2021, with a 5-year trough of $206.7 million in Q3 2022.
  • For the 5-year period, Macrogenics' Assets Average averaged around $295.4 million, with its median value being $273.4 million (2024).
  • In the last 5 years, Macrogenics' Assets Average tumbled by 4946.77% in 2022 and then surged by 5617.82% in 2023.
  • Over the past 5 years, Macrogenics' Assets Average (Quarter) stood at $363.7 million in 2021, then tumbled by 34.59% to $237.9 million in 2022, then soared by 34.17% to $319.2 million in 2023, then decreased by 17.58% to $263.1 million in 2024, then dropped by 1.89% to $258.1 million in 2025.
  • Its Assets Average stands at $258.1 million for Q3 2025, versus $235.0 million for Q2 2025 and $243.1 million for Q1 2025.